The antioxidant and antimutagenic activities of Ankaferd blood stopper,a natural hemostatic agent used in dentistry

The antioxidant and antimutagenic activities of Ankaferd blood stopper,a natural hemostatic agent used in dentistry

Background/aim: This study investigated the antioxidant and antimutagenic properties of Ankaferd blood stopper (ABS), a plant-based topical hemostatic agent used in Turkey to treat external hemorrhages and bleeding during dental surgery. While previous studies have examined the antimicrobial, antiinflammatory, and anticarcinogenic properties of ABS, to our knowledge, this is the first study to report on the antioxidant and antimutagenic activities of this drug. Materials and methods: Antioxidant activity was evaluated using DPPH radical-scavenging and β-carotene-linoleic acid tests. Antimutagenic activity was assessed using the Ames Salmonella/microsome mutagenicity test with the bacterial mutant strains Salmonella typhimurium TA98 and TA100. Results: Although ABS demonstrated no free-radical-scavenging activity in DPPH assays at the tested concentrations, β-carotenelinoleic acid testing found ABS to have a total antioxidant activity rate of 47.06 ± 4.41%. Antimutagenic effects were observed on TA100 at plate concentrations of 5%, 0.5%, and 0.05%, and on TA98 only at a plate concentration of 5%. Conclusion: ABS was shown to possess antioxidant and antimutagenic properties that could be of potential value in the fields of medicine and dentistry.

___

  • 1. Srividya AR, Dhanabal SP, Vishnuvarthan VJ. Mutagenicity/ antimutagenicity of plant extracts used in traditional medicine: a review. World J Pharm Res 2013; 2: 236–259.
  • 2. Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol 1956; 11: 298–300.
  • 3. Harman D. Mutation cancer and aging. Lancet 1961; 1: 200– 201.
  • 4. Briviba K, Sies H. Non enzymatic antioxidant defense systems. In: Frei B, editor. Natural Antioxidant in Human Health and Disease. New York, NY, USA: Academic Press; 1994. pp. 107– 128.
  • 5. Kamiya H. Mutagenic potentials of damaged nucleic acids produced by reactive oxygen/nitrogen species: approaches using synthetic oligonucleotides and nucleotides: survey and summary. Nucleic Acids Res 2003; 31: 517–531.
  • 6. Ramarathan N, Osawa NT, Namiki M, Tashiro T. Studies on the relationship between antioxidative activity of rice hull and germination ability of rice seeds. J Sci Food Agric 1986; 37: 719–726.
  • 7. Fraga CG, Arias RF, Llessuy SF, Koch OR, Boveris A. Effect of vitamin E and selenium deficiency on rat liver chemiluminescence. Biochem J 1987; 2: 383–386.
  • 8. Marnett LJ. Oxyradicals and DNA damage. Carcinogenesis 2000; 21: 361–370.
  • 9. Huang HY, Helzlsouer KJ, Appel LJ. The effects of vitamin C and vitamin E on oxidative DNA damage: results from a randomized controlled trial. Cancer Epidemiology Biomarkers & Prevention: A Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 2000; 9: 647–652.
  • 10. Chatterjee S, Zareena N, Gautam S, Soumyakanti A, Prasad SV, Arun S. Antioxidant activity of some phenolic constituents from green pepper (Piper nigrum L.) and fresh nutmeg mace (Myristica fragrans). Food Chem 2007; 101: 515–523.
  • 11. Su L, Yin JJ, Charles D, Zhou K, Moore J, Yu L. Total phenolic contents, chelating capacities and radical-scavenging properties of black peppercorn, nutmeg, rosehip, cinnamon and oregano leaf. Food Chem 2007; 100: 990–997.
  • 12. Kim SY, Shon YH, Lee JS, Kim CH, Nam KS. Antimutagenic activity of soybeans fermented with basidiomycetes in Ames/ Salmonella test. Biotechnol Let 2000; 22: 1197–1202.
  • 13. Griffiths AJF, Miller JH, Suzuki DT, Lewontin RC, Gelbart WM. An Introduction to Genetic Analysis. 7th ed. New York, NY, USA: W.H. Freeman; 2000.
  • 14. Akinboro A, Bin Mohamed K, Asmawi MZ, Yekeen TA. Antimutagenic effects of aqueous fraction of Myristica fragrans (Houtt.) leaves on Salmonella typhimurium and Mus musculus. Acta Biochim Polonica 2014; 61: 779–785.
  • 15. Kao SY, Chen YW, Chang KW, Liu TY. Detection and screening of oral cancer and pre-cancerous lesions. J Chin Med Assoc 2009; 72: 227–233.
  • 16. Johnson N. Tobacco use and oral cancer: a global perspective. J Dent Educ 2001; 65: 328–339.
  • 17. Sankaranarayanan R, Dinshaw K, Nene BM, Ramadas K, Esmy PO, Jayant K, Somanathan T, Shastry S. Cervical and oral cancer screening in India. J Med Screen 2006; 13: 35–38.
  • 18. Kada T, Inoue T, Ohta T, Shirasu Y. Antimutagens and their modes of action. In: Shankel DM, Hartman PH, Kada T, Hollaender A, editors. Antimutagenesis and Anticarcinogenesis Mechanisms. New York, NY, USA: Plenum Press; 1986. pp. 181–196.
  • 19. Kohlimeir L, Simonsen M, Mottus K. Dietary modifiers of carcinogenesis. Environ Health Perspect 1995; 103: 177–184.
  • 20. De Flora S. Mechanisms of inhibitors of mutagenesis and carcinogenesis. Mutat Res 1998; 402: 151–158.
  • 21. Nunes PX, Silva SF, Guedes RJ, Almeida S. Biological oxidations and antioxidant activity of natural products In: Rao V, editor. Phytochemicals as Nutraceuticals - Global Approaches to Their Role in Nutrition and Health. Rijeka, Croatia: InTech; 2012. pp. 1–20.
  • 22. Maxwell SRJ. Prospects for the use of antioxidant therapies. Drugs 1995; 49: 345–361. 23. Halliwell B. The antioxidant paradox. Lancet 2000; 355: 1179– 1180.
  • 24. Kaur C, Kapoor HC. Antioxidant activity and total phenolic content of some Asian vegetables. Int J Food Sci Tech 2002; 37: 153–162.
  • 25. Cesquini M, Torsoni MA, Stoppa GR, Ogo SH. tBuOHinduced oxidative damage in sickle red blood cells and the role of flavonoids. Biomed Pharmacother 2003; 57: 124–129.
  • 26. Mundhe KS, Kale AA, Gaikwad SA, Deshpande NR, Kashalkar RV. Evaluation of phenol, flavonoid contents and antioxidant activity of Polyalthia longifolia. J Chem Pharm Res 2011; 3: 764–769.
  • 27. Negi PS, Jayaprakash GK, Jena BS. Antioxidant and antimutagenic activities of pomegranate peel extracts. Food Chem 2003; 80: 393–397.
  • 28. Zahin M, Aqil F, Ahmad I. Broad spectrum antimutagenic activity of antioxidant active fraction of Punica granatum L. peel extracts. Mutat Res 2010; 703: 99–107.
  • 29. Horn RC, Vargas VMF. Antimutagenic activity of extracts of natural substances in the Salmonella/microsome assay. Mutagenesis 2003; 18: 113–118.
  • 30. Edenharder R, van Petersdorf I, Rauscher V. Antimutagenic effects of flavonoids, chalcones and structurally related compounds on the activity of 2-amino-3 methylimidazol (4,5- f) quinoline (IQ) and other heterocyclic amine mutagens from cooked food. Mutat Res 1993; 287: 261–274.
  • 31. Ruan C. Antimutagenic effect of foods and chemoprevention of cancer. Acta Guangxi Med Coll 1989; 1: 68–71.
  • 32. Işler SC, Demircan S, Çakarer S, Çebi Z, Keskin C, Soluk M, Yüzbaşıoğlu E. Effects of folk medicinal plant extract Ankaferd Blood Stopper on early bone healing. J Appl Oral Sci 2010; 18: 409–414.
  • 33. Ercetin S, Haznedaroglu IC, Kurt M, Onal IK, Aktas A, Kurt OK, Goker H, Ozdemir O, Kirazli S, Firat HC. Safety and efficacy of Ankaferd Blood Stopper in J Hemat Oncol 2010; 1: 1–5.
  • 34. Kelles M, Kalcioglu, MT, Samdanci, E, Selimoglu E, Iraz M, Miman MC, Haznedaroglu IC. Ankaferd Blood Stopper is more effective than adrenaline plus lidocaine and gelatin foam in the treatment of epistaxis in rabbits. Curr Ther Res Clin Exp 2011; 72: 185–194.
  • 35. Aysan E, Bektas H, Ersoz F, Sari S, Kaygusuz A, Huq GE. Ability of the Ankaferd blood stopper to prevent parenchymal bleeding in an experimental hepatic trauma model. Int J Clin Exp Med 2010; 3: 186–191.
  • 36. Huri E, Haznedaroglu IC, Akgul T, Astarci M, Ustun H, Germiyanoulu C. Biphasic effects of Ankaferd blood stopper on renal tubular apoptosis in the rat partial nephrectomy model representing distinct levels of hemorrhage. Saudi Med J 2010; 30: 864–868.
  • 37. Kurt M, Kacar S, Onal IK, Akdogan M, Haznedaroglu IC. Ankaferd Blood Stopper as an effective adjunctive hemostatic agent for the management of life-threatening arterial bleeding of the digestive tract. Endoscopy 2008; 40: 262.
  • 38. Kurt M, Oztas E, Kuran S, Onal IK, Kekilli M, Haznedaroglu IC. Tandem oral, rectal, and nasal administrations of Ankaferd Blood Stopper to control profuse bleeding leading to hemodynamic instability. Am J Emerg Med 2009; 27: 631: e1–e2.
  • 39. Ozaslan E, Purnak T, Yildiz A, Akar T, Avcioglu U, Haznedaroglu IC. The effect of Ankaferd blood stopper on severe radiation colitis. Endoscopy 2009; 41: 321–322.
  • 40. Kurt M, Akdogan M, Ibis M, Haznedaroglu IC. Ankaferd blood stopper for gastrointestinal bleeding. J Invest Surg 2010; 23: 239.
  • 41. Kurt M, Akdogan M, Onal IK, Kekilli M, Arhan M, Shorbagi A, Aksu S, Kurt OK, Haznedaroglu IC. Endoscopic topical application of Ankaferd Blood Stopper for neoplastic gastrointestinal bleeding: a retrospective analysis. Dig Liver Dis 2010; 42: 196–199.
  • 42. Ozaslan E, Purnak T, Yildiz A, Haznedaroglu IC. The effect of a new hemostatic agent for difficult cases of nonvariceal gastrointestinal bleeding: Ankaferd blood stopper. Hepatogastroenterology 2010; 57: 191–194. 43. Huri E, Akgul T, Ayyildiz A, Germiyanoglu C. Hemostasis in retropubic radical prostatectomy with Ankaferd Blood Stopper: a case report. Kaohsiung J Med Sci 2009; 25: 445–447.
  • 44. Teker AM, Korkut AY, Gedikli O, Kahya V. Prospective, controlled clinical trial of Ankaferd Blood Stopper in children undergoing tonsillectomy. Int J Pediatr Otorhinolaryngol 2009; 73: 1742–1745.
  • 45. Teker MA, Korkut AY, Kahya V, Gedikli O. Prospective, randomized, controlled clinical trial of Ankaferd Blood Stopper in patients with acute anterior epistaxis. Eur Arch Otorhinolaryngol 2010; 267: 1377–1381.
  • 46. Barka EA, Belarbi A, Hachet C, Nowak J. Audran JC. Enhancement of in vitro growth and resistance to gray mould of Vitis vinifera co-cultured with plant growth-promoting rhizobacteria. FEMS Microbiol Lett 2000; 186: 91–95.
  • 47. Barka EA, Gognies S, Nowak J, Audran JC, Belarbi A. Inhibitory effect of endophyte bacteria on Botrytis cinerea and its influence to promote the grapevine growth. Biol Control 2002; 24: 135–142.
  • 48. Testai L, Chericoni S, Calderone V, Nencioni G, Nieri P, Morelli I, Martinotti E. Cardiovascular effects of Urtica dioica L. (Urticaceae) roots extracts: in vitro and in vivo pharmacological studies. J Ethnopharmacol 2002; 81: 105–109.
  • 49. Matsuda H, Ando S, Kato T, Morikawa T, Yoshikawa M. Inhibitors from the rhizomes of Alpinia officinarum on production of nitric oxide in lipopolysaccharideactivated macrophages and the structural requirements of diarylheptanoids for the activity. Bioorg Med Chem 2006; 14: 138–142.
  • 50. Sheela ML, Ramakrishna MK, Salimath BP. Angiogenic and proliferative effects of the cytokine VEGF in Ehrlich ascites tumor cells is inhibited by Glycyrrhiza glabra. Int Immunopharmacol 2006; 6: 494–498.
  • 51. Lee SJ, Umano K, Shibamoto T, Lee KG. Identification of volatile components in basil (Ocimum basilicum L.) and thyme leaves (Thymus vulgaris L.) and their antioxidant properties. Food Chem 2007; 91: 131–137.
  • 52. Goker H, Haznedaroglu IC, Ercetin S, Kirazlı S, Akman U, Ozturk Y, Firat HC. Haemostatic actions of the folkloric medicinal plant extract Ankaferd Blood Stopper. J Int Med Res 2008; 36: 163–170.
  • 53. Akkoç N¸ Akçelik M, Haznedaroglu IC, Goker H, Aksu S, Kirazlı S, Fırat H. In vitro anti-bacterial activities of Ankaferd Blood Stopper. Int J Lab Hematol 2008; 30: 95.
  • 54. Akkoç N, Akçelik M, Haznedaroğlu İC, Kirazlı Ş, Fırat HC. The comparison of the in vitro anti-microbial effects of Ankaferd Proteomix food support and Ankaferd Sır cosmetic preparat. In: The 10th National Congress of Internal Medicine Congress Book; 15–19 October 2008; Antalya, Turkey: abstract no: P219 (in Turkish).
  • 55. Berktaş M, Yaman G, Ayhan H, Aksakal A, Güdücüoğlu H, Öztürk Ö, Parlak M. Ankaferd Blood Stopper: is it an antibiotic precursor as well? In: The 34th National Congress of Haematology (Proceedings Book); 8–11 October 2008; Çeşme, İzmir, Turkey: abstract no: P0146 (in Turkish).
  • 56. Fışgın NT, Çaycı YT, Çoban AY, Özatlı D, Tanyel E, Tülek N. The antimicrobial efficacy of Ankaferd Blood Stopper, a composition of plant extracts. In: The 34th National Congress of Haematology (Proceedings Book); 8–11 October 2008; Çeşme, İzmir, Turkey: abstract no: P078 (in Turkish).
  • 57. Fisgin NT, Cayci YT, Coban AY, Ozatli D, Tanyel E, Durupinar B, Tulek N. Antimicrobial activity of plant extract Ankaferd Blood Stopper. Fitoterapia 2009; 80: 48–50.
  • 58. Saribas Z, Sener B, Haznedaroglu IC, Hascelik G, Kirazli S, Goker H. Antimicrobial activity of Ankaferd Blood Stopper against nosocomial bacterial pathogens. Cent Eur J Med 2010; 5: 198–202.
  • 59. Akkoç N, Akçelik M, Haznedaroğlu İC. Göker H, Turgut M, Aksu S, Kirazlı Ş, Fırat HC. Definition of in vitro anti-fungal effects of Ankaferd medical plant extract. In: The 34th National Congress of Haematology (Proceedings Book); 8–11 October 2008; Çeşme, İzmir, Turkey: abstract no: S017 (in Turkish).
  • 60. Koçak E, Akbal E, Taş A, Köklü S, Karaca G, Can M, Kösem B, Üstün H. Anti-inflammatory efficiency of Ankaferd blood stopper in experimental distal colitis model. Saudi J Gastroenterol 2013; 19: 126–130.
  • 61. Göker H, Uçar Çetinkaya D, Kılıç E, Haznedaroğlu İC, Kirazlı Ş, Fırat HC. The in vitro anticancer activity of Ankaferd Blood Stopper (ABS) on osteosarcoma (Saos-2) cell lines. In: The 34th National Congress of Haematology (Proceedings Book); 8–11 October 2008; Çeşme, İzmir, Turkey: abstract no: P066 (in Turkish).
  • 62. Göker, Kılıç E, Uçar Çetinkaya D, Büyükaşık Y, Aksu S, Turgut M, Haznedaroğlu İC. The in vitro anticancer activity of Ankaferd on human colon cancer (CaCo-2) cells. The 10th National Congress of Internal Medicine Congress Book; 15–19 October 2008; Antalya, Turkey: abstract no: P044 (in Turkish).
  • 63. Beyazit Y, Kurt M, Kekilli M, Goker H, Haznedaroglu IC. Evaluation of hemostatic effects of Ankaferd as an alternative medicine. Altern Med Rev 2010; 15: 329–336.
  • 64. Yılmaz E, Güleç S, Torun D, Haznedaroğlu İC, Akar N. The effects of Ankaferd Blood Stopper on transcription factors in HUVEC and erythrocyte protein profile. Turk J Hematol 2011; 28: 276–285.
  • 65. Mortelmans K, Zeiger E. The Ames Salmonella/microsome mutagenicity assay. Mutat Res 2000; 455: 29–60.
  • 66. Oh HT, Kim SH, Choi HJ, Chung MJ, Ham SS. Antioxidative and antimutagenic activities of 70% ethanol extract from masou salmon (Oncorhynchus masou). Toxicol In Vitro 2008; 22: 1484–1488.
  • 67. Yamasaki K, Hashimoto A, Kokusenya Y, Miyamoto T, Sato T. Electrochemical method for estimating the antioxidative effects of methanol extracts of crude drugs. Chem Pharm Bullet 1994; 42: 1663–1665.
  • 68. Jayaprakasha GK, Jaganmohan Rao L. Phenolic constituents from lichen Parmotrema stuppeum (Nyl.). Hale and their antioxidant activity. Zeitsch Naturforsch 2000; 55C: 1018– 1022.
  • 69. Santana-Rios G, Orner GA, Amantana A, Prowost C, Wu SY, Dashwood RH. Potent antimutagenic activity of white tea in the Salmonella assay. Mutat Res 2001; 495: 61–74.
  • 70. Yu Z, Xu M, Santana-Rios G, Shen R, Izquierdo-Pulido M, Williams DE, Dashwood RH. A comparison of whole wheat, refined wheat and wheat bran as inhibitors of heterocyclic amines in the Salmonella mutagenicity assay and in the rat colonic aberrant crypt focus assay. Food Chem Toxicol 2001; 39: 655–665.
  • 71. Maron DM, Ames BN. Revised methods for the Salmonella mutagenicity test. Mutat Res 1983; 113: 173–215.
  • 72. Sarac N, Sen B. Antioxidant, mutagenic, antimutagenic activities, and phenolic compounds of Liquidambar orientalis Mill. var. orientalis. Ind Crops Prod 2014; 53: 60–64.
  • 73. Evandri MG, Battinelli L, Daniele C, Mastrangelo S, Bolle P, Mazzanti G. The antimutagenic activity of Lavandula angustifolia (lavender) essential oil in the bacterial reverse mutation assay. Food Chem Toxicol 2005; 43: 1381–1387.
  • 74. Shureiqi I, Reddy P, Brenner DE. Chemoprevention: general perspective. Crit Rev Oncol/Hematol 2000; 33: 157–167.
  • 75. Tsao AS, Kim ES, Hong WK. Chemoprevention of cancer. CA-A Cancer J Clinic 2004; 54: 150–180.
  • 76. Khalaf NA, Shakya AK, Al-Othman A, El-Agbar Z, Farah H. Antioxidant activity of some common plants. Turk J Biol 2008; 32: 51–55.
  • 77. Shon MY, Choi SD, Kahng GG, Nam SH, Sung NJ. Antimutagenic, antioxidant and free radical scavenging activity of ethyl acetate extracts from white, yellow and red onions. Food Chem Toxicol 2004; 42: 659–666.
  • 78. Ghazali R, Abdullah R, Ramli N, Rajab NF, Ahmad-Kamal MS, Yahya NA. Mutagenic and antimutagenic activities of Mitragyna speciosa Korth extract using Ames test. J Med Plants Res 2011; 5: 1345–1348.
Turkish Journal of Medical Sciences-Cover
  • ISSN: 1300-0144
  • Yayın Aralığı: Yılda 6 Sayı
  • Yayıncı: TÜBİTAK
Sayıdaki Diğer Makaleler

Evaluation of tetanus antibody levels in adults in Yozgat, Turkey

Ayşe ERBAY, Çiğdem KADER, Mehmet BALCI

Mukadder ŞANLI, Nurçin GÜLHAŞ, Bilge Türk BİLEN, Gülay Erdoğan KAYHAN, Muharrem UÇAR, Ahmet Hamdi AYTEKİN, Saim YOLOĞLU

Effects of a self-management educational program on metabolic control in type 2 diabetes

Hossein Ali SADEGHIAN, Kamal AGRAWAL, Aanjor Tupil KANNAN, Kireet AGRAWAL, Sri Venkata MADHU

Sevim YAVAŞ, Meltem Arzu YETKİN, Bircan KAYAASLAN, Aliye BAŞTUĞ, Halide ASLANER, Ayşe BUT, Dilek KANYILMAZ, Berrin SARI, Esragül AKINCI, Hurrem BODUR

Ayşe Ebru KILAVUZOĞLU, Tansu GÖNEN, Ali Riza Cenk ÇELEBİ, Cemile Banu Coşar YURTERİ, Asim Bozkurt ŞENER

Evaluation of behavioral problems in patients with monosymptomaticnocturnal enuresis: a prospective controlled trial

Zeynep Yeşim ÖZCAN, Musab Ali KUTLUHAN, Bilal KARAMAN, Muhammet İhsan KARAMAN, Mehmet AKYÜZ, Metin İshak ÖZTÜRK, Orhan KOCA

Aik Hoe YEOH, Shereen Suet Ping TANG, Norsidah Abdul MANAP, Wan Rahiza Wan MAT, Shuraya SAID, Muhamad Rahimi Che HASSAN, Raha Abdul RAHMAN

Determination of virulence and multidrug resistance genes with polymerase chain reaction method in vancomycin-sensitive and -resistant enterococci isolated from clinical samples

Jülide Sedef GÖÇMEN, Şükran SABA ÇOPUR, Fikret ŞAHİN

Shazia Anwer BUKHARI, Kashaf ZAFAR, Muhammad İbrahim RAJOKA, Zubair IBRAHIM, Sadia JAVED, Rafshan SADIQ

eNOS gene polymorphisms in paraffin-embedded tissues of prostate cancer patients

Meral YILMAZ, Nesrin TURAÇLAR, Fikriye POLAT, Günsel BİNGÖL, Hasibe CİNGİLLİ VURAL